Panel hints too many get coated stents
FDA advisers shake heads at the rising use in more complex cases
GAITHERSBURG, Md. -- Federal advisers yesterday said that drug-coated stents, which have been implanted in millions, offer clear benefits to many patients but present higher clotting risks to others, suggesting they may be overused. (Full article: 562 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
